Cargando…

An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia

Treatment responses of patients with acute myeloid leukemia (AML) are known to be heterogeneous, posing challenges for risk scoring and treatment stratification. In this retrospective multi-cohort study, we investigated whether combining pyroptosis- and immune-related genes improves prognostic class...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Weikaixin, He, Liye, Zhu, Jie, Brück, Oscar, Porkka, Kimmo, Heckman, Caroline A., Zhu, Sujie, Aittokallio, Tero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522598/ https://www.ncbi.nlm.nih.gov/pubmed/35945345 http://dx.doi.org/10.1038/s41375-022-01662-6

Ejemplares similares

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
por: Adnan Awad, Shady, et al.
Publicado: (2020)

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
por: Malani, Disha, et al.
Publicado: (2022)

Systematic review of computational methods for drug combination prediction
por: Kong, Weikaixin, et al.
Publicado: (2022)

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2020)

Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia
por: White, Brian S., et al.
Publicado: (2021)

Chronic myeloid leukemia patients’ adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians
por: Kekäle, Meri, et al.
Publicado: (2014)

Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer
por: Huang, Liting, et al.
Publicado: (2021)

Real‐world experience of novel multiple myeloma treatments in a large, single‐center cohort in Finland
por: Loponen, Heidi, et al.
Publicado: (2023)

A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia
por: Huang, Kecheng, et al.
Publicado: (2022)

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
por: Adnan-Awad, Shady, et al.
Publicado: (2020)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis
por: Zhu, Jie, et al.
Publicado: (2023)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)

Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia
por: Zhong, Guangcai, et al.
Publicado: (2023)

A ferroptosis-related gene signature and immune infiltration patterns predict the overall survival in acute myeloid leukemia patients
por: Yin, Zhao, et al.
Publicado: (2022)

The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
por: Zhou, Tao, et al.
Publicado: (2022)

An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
por: Ragaini, Simone, et al.
Publicado: (2022)

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
por: He, Liye, et al.
Publicado: (2015)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity
por: Schiffer, Charles A., et al.
Publicado: (2016)

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
por: Dowling, Paul, et al.
Publicado: (2021)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma
por: Dong, Zheng, et al.
Publicado: (2021)

MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer
por: Zhu, Jie, et al.
Publicado: (2022)

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
por: Pietarinen, Paavo O., et al.
Publicado: (2017)

Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2022)

Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
por: Zhang, Liuyan, et al.
Publicado: (2019)

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy
por: Ilander, Mette, et al.
Publicado: (2014)

DPP8/9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia
por: Johnson, Darren C., et al.
Publicado: (2018)

Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Zheng, Susu, et al.
Publicado: (2021)

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
por: El Missiry, Mohamed, et al.
Publicado: (2017)

A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer
por: Fu, Yang, et al.
Publicado: (2021)

The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia
por: Sha, Yeqin, et al.
Publicado: (2022)

New Pyroptosis -Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

Pyroptosis-related gene-based prognostic signature for predicting the overall survival of oral squamous cell carcinoma patients
por: Zeng, Deliang, et al.
Publicado: (2022)

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8m7l7bg9od26230mhr3nktq0ks